MDMA therapy for cancer patients and their partner’s distress
Treatments studied
Part of Cancer, Mental health clinical trials.
This Phase 2 study tests whether MDMA-assisted therapy can reduce adjustment-related distress in cancer patients who are paired with a loved one who is also concerned. It may help the patient and their significant other cope better through structured therapy sessions, with safety checks before and after each session.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You and a key partner (spouse/close family) must be part of the dyad in the study
- You must have adjustment disorder as your current diagnosis (not caused by another mental condition or normal grief)
- You must be able to swallow pills and have a safe ride home after each session, with no driving until the therapists say it’s safe
- You must be able to speak and read English and agree to audio/video recordings of visits
- If you could become pregnant, you must use effective birth control and do pregnancy tests at the start and before each session
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether MDMA combined with structured therapy can reduce stress symptoms in people who have been exposed to major work-related stress in healthcare or emergency response. It’s designed to help participants during special “experimental” sessions plus regular therapy sessions without MDMA.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
This trial tests if a single dose of psilocybin, given with therapy, can help cancer survivors who struggle with anxiety or depression. You would travel to MD Anderson for treatment and follow-up, and must stop certain medications beforehand.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
This Phase 2 study tests whether MDMA combined with therapy that uses exposure (gradual confronting of trauma memories) can reduce PTSD symptoms. It may help people who meet PTSD criteria, can follow strict safety rules, and can complete medicine-session monitoring.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.